Market Analysis — MARGARETVILLE HOSPITAL
NY market | 3 hospitals | HHI: 3,695 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
56
Total Beds
$0.1B
Market Revenue
Concentrated
HHI: 3,695
None
Moat Rating (4/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share22.3%
Top 3 Concentration100.0%
Network Density3.00
Margin vs Market+7.4%
Bed Util vs Market-34.1%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The NY market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 3,695).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full NY market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| DELAWARE VALLEY HOSPITAL | 25 | $33M | 48.3% | 44.6% |
| OCONNOR HOSPITAL | 16 | $20M | 29.4% | 28.6% |
Regional Payer Mix
■ Medicare 44%■ Medicaid 4%■ Commercial 52%